Innovative self-care company

MedicaNatumin

MedicaNatumin develops, manufactures and markets health and beauty products based on innovative ingredients and research. The company’s patented platforms were developed by its own research group in collaboration with Karolinska Institute and Sahlgrenska Academy. MedicaNatumin’s leading brands of food supplements, medical devices, and dermatological and cosmetic products are widely sold in the Nordic market, but also to consumers around the world. Its sales channels consist of specialty retail, department stores, pharmacies and e-commerce. For sales outside of the Nordics, MedicaNatumin uses distributors. Its HQ and production are in Jönköping and Habo. The group targets SEK 200m in sales for 2020.

Financials

MEDICANATUMIN

SEKm 2018 2019 2020
Sales 194 166 173
Sales growth (%) 51,7 -14,5 4,2
EBITDA 55 30 N/A
EBITDA margin (%) 9,6 28,2 18,4
EBIT adj 3 47 21
EBIT adj margin (%) 2,4 24 12,9
Pretax profit 47 21 22
EPS rep 0,1 0,04 0,05
EPS growth (%) 709,5 -54,8 4,8
EPS adj 0,1 0,04 0,05
DPS 0 0 0
EV/EBITDA (x) 5 8,2 7,1
EV/EBIT adj (x) 5,9 11,7 10,3
P/E (x) 8 17,6 16,8
P/E adj (x) 8 17,6 16,8
EV/sales (x) 1,4 1,5 1,3
FCF yield (%) 11,8 8,8 7
Dividend yield (%) 0 0 0
Net IB debt/EBITDA -0,3 -1,3 -1,9

Main shareholders

MedicaNatumin

Main shareholders Share capital % Voting shares % Verified
N.P.H I Habo AB 20.1 % 20.1 % 31 Dec 2018
Swedbank Försäkring 11.1 % 11.1 % 31 Dec 2018
Avanza Pension 9.7 % 9.7 % 31 Dec 2018
Familjen Jakob & Bengt Johansson 8.4 % 8.4 % 30 Sep 2018
Jool Invest AB 4.7 % 4.7 % 31 Dec 2018
TJ Gruppen AB 4.7 % 4.7 % 31 Dec 2018
Lars Johansson 2.3 % 2.3 % 31 Dec 2018
Jesper Pettersson 2.2 % 2.2 % 31 Dec 2018
Jörgen Wehmonen 1.9 % 1.9 % 31 Dec 2018
Karl Olov Eriksson 1.9 % 1.9 % 31 Dec 2018
Source: Holdings by Modular Finance AB

Insider list

MedicaNatumin

Name
Ulrika Albers
Ulrika Albers
ML i Habo AB
Lars Magnus Kärnerud
Lars Magnus Kärnerud
Bengt Johansson
Bengt Johansson
Bengt Johansson
Bengt Johansson
Andreas Skiöld
Show More